Sunshine Act Prompts Pharma Companies To Alter Grant Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer may demand a CME grant recipient return funding if the data it submits is inaccurate; impact on speaker bureaus is anticipated.